A detailed history of Counterweight Ventures, LLC transactions in Amgen Inc stock. As of the latest transaction made, Counterweight Ventures, LLC holds 7,330 shares of AMGN stock, worth $2.34 Million. This represents 1.73% of its overall portfolio holdings.

Number of Shares
7,330
Previous 7,125 2.88%
Holding current value
$2.34 Million
Previous $2.03 Billion 13.06%
% of portfolio
1.73%
Previous 1.63%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$262.75 - $319.31 $53,863 - $65,458
205 Added 2.88%
7,330 $2.29 Billion
Q1 2024

May 01, 2024

SELL
$268.87 - $324.56 $80,392 - $97,043
-299 Reduced 4.03%
7,125 $2.03 Billion
Q4 2023

Feb 27, 2024

BUY
$255.7 - $288.46 $1.9 Million - $2.14 Million
7,424 New
7,424 $2.14 Billion

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Counterweight Ventures, LLC Portfolio

Follow Counterweight Ventures, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Counterweight Ventures, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Counterweight Ventures, LLC with notifications on news.